All News

Found 5,694 articles

• Cytogen Corporation Reports Fourth Quarter And Full Year 2005 Financial Results

  2/23/2006

• P D McGrath Receives 510(k) Clearance To Market Sucralfate HCl Topical Paste(TM)

  2/22/2006

• Corgentech, Inc. Anesthetic Shows Positive Results In Late-Stage Trial

  2/21/2006

• Evotec OAI (Germany) And Apeiron Biologics To Discover Novel Pain Therapeutics

  2/14/2006

• Axcan Pharma Announces Record Revenue Of $70.6 Million For The First Quarter Of Fiscal 2006

  2/10/2006

• Corgentech, Inc. Completes Patient Enrollment In Three Phase 2 Clinical Trials Of Post-Surgical Pain Drug Candidate

  2/9/2006

• DURECT Corporation Announces Anticipated Development Program Milestones For Fiscal Year 2006

  2/8/2006

• MedImmune, Inc. Reports 2005 Financial Results; Posts $22 Million Loss

  2/2/2006

• Halozyme Therapeutics, Inc. Initiates Clinical Trial Of Subcutaneous Morphine With Hylenex

  2/2/2006

• Sucampo Pharmaceuticals, Inc. Obtains FDA Approval For AMITIZA(TM) Capsules As Treatment For Chronic Idiopathic Constipation In Adults

  1/31/2006

• Laserscope Announces Issuance Of U.S. Patent

  1/27/2006

• YM BioSciences' Subsidiary Delex Therapeutics Inc. Announces Enrollment Of First Patient In Phase IIb Trial For The Treatment Of Acute Pain With AeroLEF(TM)

  1/26/2006

• Cytogen Corporation Announces Publication Of Peer Reviewed Preclinical Data Demonstrating Anticancer Activity Of QUADRAMET(R) In Multiple Myeloma

  1/24/2006

• Pfizer Inc. Fourth-Quarter And Full-Year 2005 Financial Results Reflect Operating And Financial Strength

  1/19/2006

• Nuvo Research Inc. Sells Additional Canadian Pennsaid(R) Eights To Paladin Labs Inc. Subsidiary

  1/17/2006

• Nuvo Research Inc. Reports Detailed Phase III Pennsaid(R) Clinical Results

  1/16/2006

• LAB International Licenses Fentanyl TAIFUN(R) For Japan

  1/11/2006

• Berlex Inc. Release: FDA Approves Osteoporosis Indication For Once-A-Week Hormone Therapy Patch, Climara Pro(R)

  1/4/2006

• Nascent Pharmaceuticals, Inc. Reports Positive Results For Phase II Dry Eye Treatment

  1/4/2006

• Corgentech, Inc. And AlgoRx Pharmaceuticals, Inc. Complete Merger Creating Late-Stage Company Addressing Pain Management And Inflammation

  12/16/2005